Silver-Lined catheter shows promise in keeping cancer Patients' lungs Fluid-Free
NCT ID NCT02649894
First seen Jan 05, 2026 · Last updated May 23, 2026 · Updated 21 times
Summary
This study tested a new silver-coated tube (catheter) placed in the chest to prevent fluid from building up again in cancer patients with malignant pleural effusion. 119 adults with recurrent, symptomatic fluid around the lungs were randomly assigned to get either the silver-coated tube or a standard uncoated tube. The goal was to see if the silver coating helped seal the lung space and keep fluid from coming back, improving breathing and comfort.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MALIGNANT PLEURAL EFFUSION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Beth Israel Deconess Medical Center West
Boston, Massachusetts, 02215, United States
-
Duke University
Durham, North Carolina, 27710, United States
-
Great Western Hospital
Swindon, United Kingdom
-
Heart Center Research
Huntsville, Alabama, 35801, United States
-
Huntsman Cancer Institute
Salt Lake City, Utah, 84112, United States
-
Johns Hopkins Hospital
Baltimore, Maryland, 21287, United States
-
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
-
Moffitt Cancer Center
Tampa, Florida, 33612, United States
-
Northwestern Unversity
Chicago, Illinois, 60611, United States
-
Oxford Center for Respiratory Medicine, Churchill Hospital
Oxford, United Kingdom
-
SUNY Upstate Hospital
Syracuse, New York, 13210, United States
-
Southmead Hospital
Bristol, United Kingdom
-
St. Vincent Medical Group
Indianapolis, Indiana, 46260, United States
-
Stanford University School of Medicine/ Stanford Cancer Institute
Stanford, California, 94305, United States
-
UNC Hospital
Chapel Hill, North Carolina, 27599, United States
-
University of Nebraska Medical Center
Omaha, Nebraska, 68198, United States
-
University of Texas, MD Anderson Cancer Center
Houston, Texas, 77030, United States
-
Vanderbuilt University
Nashville, Tennessee, 37232, United States
-
Washington Universtiy School of Medicine, Barnes Jewish Hospital
St Louis, Missouri, 63110, United States
Conditions
Explore the condition pages connected to this study.